Candilactom

Candilactom is available in the form of capsules, in boxes of 10. Each capsule is rich in Lactobacillus rhamnosus TOM 22.8, providing at least 10 billion colony-forming units (CFU) of this strain.

The capsule form makes this product easy to take and helps ensure accurate and consistent dosing throughout the recommended course of treatment.

The main indications for Candilactom include the management and relief of symptoms associated with candidiasis and bacterial vaginosis.

The product works effectively to restore the natural balance of the vaginal microbiota, thus preventing the proliferation of pathogens.

Candilactom is also recommended for women who experience frequent vulvovaginal discomfort, offering a non-invasive alternative with no significant side effects.

Candilactom is simple to administer and easy to integrate into a daily routine.

For adults, it is recommended to take one capsule per day, for a period of 10 days. This treatment regimen is effective in ensuring a constant amount of Lactobacillus rhamnosus TOM 22.8 in the body, helping to maintain a healthy vaginal environment.

Although Candilactom is generally safe to use, there are certain contraindications that should be considered.

This supplement is not recommended for people with hypersensitivity or known allergy to any of its ingredients. It is also recommended to consult a doctor before starting treatment in people with severe pre-existing medical conditions or who are undergoing medical treatment.

Candilactom is compatible with gluten-free and lactose-free diets, making it suitable for people with food intolerances.

The Lactobacillus rhamnosus TOM 22.8 strain is extremely resistant to the acidic conditions of the stomach and bile salts, thus ensuring increased effectiveness in reaching the target area without being destroyed during intestinal transit.

In general, Candilactom is well tolerated by users. However, as with any dietary supplement, there may be isolated cases of adverse reactions, such as minor gastrointestinal disturbances. These effects are usually temporary and disappear with continued treatment.

To date, no significant interactions between Candilactom and other medicines or foods have been reported. However, caution is advised and a specialist should be consulted in case of concomitant use with antibiotics or other treatments that alter the intestinal and vaginal microbiota.

There are no documented reports of overdose with Candilactom.

However, it is essential that users adhere to the recommended dosage regimen and do not exceed the daily dose without the approval of a medical specialist.

To ensure the stability and efficacy of the product, Candilactom should be stored in a cool, dry place, away from direct exposure to light and moisture. It is important that the product is stored in its original packaging to protect the capsules from contamination from the external environment and to maintain the viability of the probiotics throughout the shelf life.

Keep out of reach of children.

• PubMed, Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis by increasing the population of lactobacilli
• PubMed, A pilot clinical study of the effect of the probiotic strain Lacticaseibacillus rhamnosus TOM 22.8 in women with vaginal dysbiosis
• ScienceDirect, Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to the management of bacterial vaginosis
• Cleveland Clinic, Are probiotics good for vaginal health?